SCHEMBL92540

SCHEMBL92540

CCN1/C(=C/C=C/c2ccc3cc(CN)ccc3[n+]2CC)C=Cc2ccccc21

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 12/20 0.75
KMT2A Q03164 12/20 0.75
HTT P42858 8/20 0.75
BLM P54132 3/20 0.75
THRB P10828 1/20 0.75
TDP1 Q9NUW8 1/20 0.75
SLC22A3 O75751 2/20 0.57
SLC22A2 O15244 1/20 0.57
SLC22A1 O15245 1/20 0.57
NQO2 P16083 1/20 0.57
MAPT P10636 8/20 0.56
POLB P06746 7/20 0.56
LMNA P02545 5/20 0.56
RAB9A P51151 5/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
NPSR1 Q6W5P4 5/20 0.56
ALDH1A1 P00352 5/20 0.56
RECQL P46063 4/20 0.56
PKM P14618 3/20 0.56
ALPG P10696 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinaldine Blue SCHEMBL29837418 0.86 MEN1 (1.00) MEN1KMT2AHTTBLMTHRB
Quinaldine Blue SCHEMBL12302233 0.86 MEN1 (1.00) MEN1KMT2AHTTBLMTHRB
Quinaldine Blue SCHEMBL2413213 0.86 MEN1 (1.00) MEN1KMT2AHTTBLMTHRB
Quinaldine Blue SCHEMBL5847479 0.86 MEN1 (1.00) MEN1KMT2AHTTBLMTHRB
Quinaldine Blue SCHEMBL12284820 0.86 MEN1 (1.00) MEN1KMT2AHTTBLMTHRB
Quinaldine Blue SCHEMBL6128354 0.86 MEN1 (1.00) MEN1KMT2AHTTBLMTHRB
SCHEMBL15196596 0.86 MEN1 (0.68) MEN1KMT2AHTTBLMTHRB
Quinaldine Blue SCHEMBL58012 0.85 MEN1 (0.98) MEN1KMT2AHTTBLMTHRB
Quinaldine Blue SCHEMBL636794 0.85 MEN1 (0.98) MEN1KMT2AHTTBLMTHRB
Quinaldine Blue SCHEMBL30688825 0.85 MEN1 (0.98) MEN1KMT2AHTTBLMTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129315-B2 Labelling strategies for the sensitive detection of analytes BASECLICK GMBH (DE) 2012-03-06 US disclosed
EP-2266996-A2 New labelling strategies for the sensitive detection of analytes baseclick GmbH (DE) 2010-12-29 EP disclosed
EP-2256126-A1 New labelling strategies for the sensitive detection of analytes baseclick GmbH (DE) 2010-12-01 EP disclosed
US-20090215635-A1 LABELLING STRATEGIES FOR THE SENSITIVE DETECTION OF ANALYTES BASF SE (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215635-A1 LABELLING STRATEGIES FOR THE SENSITIVE DETECTION OF ANALYTES MTREX, ADAR, GUSB MEN1 3181/4885KMT2A 2047/4885HTT 1377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.